Andrew J. Forman

Washington,  DC  U.S.A.

Peer Rating

Client Rating

Printer Friendly VersionEmail this PageDownload to My Outlook ContactsAdd lawyer to My FavoritesCompare this lawyer to other lawyers in your favorites

Experience & Credentials

Practice Areas

  • Antitrust
  • Antitrust Litigation & Civil Investigations
  • M&A Clearance & Counseling
  • Grand Jury and Cartel Investigations, Amnesty, and Compliance
  • Litigation
Contact InfoTelephone: 202-862-2243
Fax: 202 862 2400
University Washington University, St. Louis, B.A., with honors, 1995
Law SchoolGeorgetown University Law Center, J.D., cum laude, 2000
Admitted2000, Maryland; 2002, District of Columbia

Andrew Forman's practice involves counseling clients in a wide range of antitrust matters, with a specific focus on mergers and acquisitions, joint ventures, and representing clients in connection with investigations by the U.S. Department of Justice and the Federal Trade Commission (FTC). Andy also has experience in private antitrust litigation, including antitrust class action litigation. He has represented clients in matters involving a variety of industries, including the pharmaceutical, medical device, airline, automobile, software, semiconductor, industrial and engineered products, and consumer products industries. Among the clients Andy has represented are Eli Lilly, Salix, Anheuser-Busch InBev, US Airways, Pfizer, Microsoft, and Goodyear.

Recognized as a leading antitrust lawyer, Andy has helped lead the Cadwalader teams that have won the last two Global Competition Review antitrust Matter of the Year awards, in 2015 for work with Eli Lilly & Company in connection with its acquisition of Novartis Animal Health and in 2014 for work in connection with the US Airways/American Airlines merger. He also was recommended in The Legal 500 (2012 -2013) for his work in merger clearances and was part of the team accepting Benchmark Litigation's award for 2013 U.S. Antitrust Group of the Year and for a national Impact Case of the Year awardfor the US Airways/American merger clearance.

Prior to joining Cadwalader, Andy worked for the FTC's Bureau of Competition (Mergers I), where he helped lead antitrust investigations in large mergers and acquisitions in the pharmaceutical, medical device, consumer products, industrial products, and aircraft components industries.

Andy received his J.D., cum laude, from Georgetown University and his undergraduate degree as an Honors Graduate from Washington University in St. Louis. Following law school, he served as a judicial law clerk for the D.C. Court of Appeals. He is admitted to the bar in the District of Columbia and Maryland.


Antitrust representations include:

•Antitrust counsel to Cigna in connection with its $54 billion merger with Anthem Health.
•Novant Health in its sale of outpatient diagnostic imaging centers to Northside Hospital.
•Aer Lingus in International Airline Group's $1.4 billion offer for Aer Lingus.
•Salix Pharmaceuticals, Ltd. in its $15.6 billion acquisition by Valeant Pharmaceuticals International, Inc.
•Eli Lilly & Company in connection with its $5.4 billion acquisition of Novartis Animal Health.
•Acorda Therapeutics, Inc. in its pending acquisition of Civitas Therapeutics, Inc.
•Salix Pharmaceuticals in connection with its proposed transaction with Cosmo Technologies.
•US Airways in its $17 billion merger with American Airlines.
•Vertis Holdings, Inc., an advertising and direct mail company, in connection with its bankruptcy sale to rival Quad/Graphics, Inc.
•US Airways in its slot transaction with Delta Air Lines.
•Pfizer Inc. in its $68 billion acquisition of Wyeth Pharmaceuticals.
•Microsoft Corporation in numerous antitrust matters.
•elan Corporation PLC in the $3.3 billion sale of its multiple sclerosis joint venture interest to Biogen Idec, Inc.
•Anheuser-Busch InBev in various antitrust matters.
•Goodyear Tire & Rubber Company in various antitrust matters.

News & Resources


News Releases

Cadwalader Recognized with Two Awards at The 7th Annual Americas M&A Atlas Awards Nov 04, 2015

Recent Press

New Deals - Lawyers on Major Transactions Jan 29, 2009


Cadwalader Recognized in 2016 Edition of The Best Lawyers in America Aug 17, 2015


Clients & Friends Memos

Recent Court and Agency Actions Suggest Increased Antitrust Risk Over Disgorgement, Particularly in the Pharmaceutical Industry May 05, 2015


Merger Control in the United States: Lexology Navigator Q&A Jul 03, 2015


So The Agency Wants to Talk: Advice and Issues in Pre-Complaint Depositions Mar 16, 2015


Aer Lingus' Nine-Year Struggle with Ryanair Culminates in a Notable Series of Judgments and Clearances Over a 29-Hour Period Oct 02, 2015


Senior Judges' Chambers
District of Columbia Court of Appeals


Documents by this lawyer on

Subscribe to this feed

FTC Announces 2016 Thresholds for Merger Control Filings Under HSR Act and Interlocking Directorates Under the Clayton Act
Andrew J. Forman,Ngoc Pham Hulbig,Jonathan S. Kanter,Christian J. Lorenz,Charles F. (Rick) Rule, February 4, 2016
The Federal Trade Commission (“FTC”) has announced its annual revisions to the dollar jurisdictional thresholds in the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the “HSR Act”); the revised thresholds are expected to become effective in late February...

Recent Court and Agency Actions Suggest Increased Antitrust Risk Over Disgorgement, Particularly in the Pharmaceutical Industry
Andrew J. Forman,Daniel J. Howley,Charles F. (Rick) Rule,Eric Sega, May 13, 2015
Recent court and agency rulings highlight important takeaways involving disgorgement in antitrust proceedings. Companies, especially those in the pharmaceutical industry, increasingly should ensure they properly calibrate the potential for disgorgement in their antitrust risk calculus.

Takeaways from the Ninth Circuit’s Opinion Affirming the FTC’s Victory Against the St. Luke's/Saltzer Merger
Andrew J. Forman,Daniel J. Howley,Jonathan S. Kanter,Charles F. (Rick) Rule,Eric Sega, March 26, 2015
On February 10, 2015, the United States Court of Appeals for the Ninth Circuit affirmed a district court’s ruling that St. Luke’s Health System’s acquisition of the independent physician group Saltzer Medical Group violated the antitrust laws. This appellate victory is another in...
Profile Visibility
#3,118 in weekly profile views out of 58,027 lawyers in Washington, District of Columbia
#110,987 in weekly profile views out of 1,739,582 total lawyers Overall

Office Information

Andrew J. Forman

700 Sixth Street, N.W.
WashingtonDC 20001


Professional Networking for Legal Professionals Only

Quickly and easily expand your professional
network - join the premier global network for legal professionals only. It's powered by the
Martindale-Hubbell database - over 1,000,000 lawyers strong.
Join Now